Industry | 2009.12.18
Biovator and BASF Sign Technology Development Agreement
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries. “Allergic reactions to compounds are a serious risk in new products that needs to be discovered in
For more information, please visit
http://www.businesswire.com/news/home/20091218005187/en
